ESD

ESD (Esterase D) is a catalytically active serine hydrolase whose enzymatic activity is detectable in human tissue and, beyond classical esterase function, extends to a nonclassical deacetylase activity acting on serine/threonine residues (PMID:33615471, PMID:21596165). In the context of cholesterol homeostasis, ESD localizes to lysosomes, interacts with JAB1 (Jun activation domain binding protein 1), and removes the Thr89 acetyl mark from JAB1 to increase its activity; activated JAB1 in turn promotes ABCA1 expression to accelerate cholesterol efflux, an axis that lowers blood cholesterol and inhibits foam cell formation in apoE-/- mice and oxLDL-treated cells (PMID:33615471). The coding sequence of ESD has been resolved at the variant level, including missense polymorphisms and a premature-stop null allele that abolishes protein production (PMID:15481680, PMID:12062949). Beyond the JAB1–ABCA1 cholesterol-efflux axis and its catalytic activity in human tissue, no further mechanistic detail has been characterized in the available corpus.

1. 2002 Medium

   Establishing the molecular genetics of ESD: defining a null allele clarified that specific coding mutations can fully abolish ESD protein production, framing the gene's allelic landscape.

   Evidence PCR and DNA sequencing of all eight coding exons from a forensic paternity case identifying a C-to-T transition creating a premature stop at codon 63

   PMID:12062949

   Open questions at the time

   • Does not address ESD protein function or biochemical activity
   • Single case observation
2. 2004 Medium

   Characterizing common and rare ESD allelic variants at the amino-acid level mapped the polymorphic coding architecture of the gene across populations.

   Evidence PCR amplification, DNA sequencing, and intragenic SNP haplotype analysis in German and Japanese populations

   PMID:15481680

   Open questions at the time

   • No functional consequence assigned to the identified amino-acid substitutions
   • Does not connect variants to enzymatic activity or disease
3. 2011 Low

   Demonstrating that ESD's serine hydrolase activity is catalytically active in human tissue established the protein as a functional enzyme in vivo rather than an inferred activity.

   Evidence Activity-based protein profiling coupled to mass spectrometry on 40 paired human lung adenocarcinoma and non-neoplastic tissue samples

   PMID:21596165

   Open questions at the time

   • Single activity-based method with no mutagenesis confirming the catalytic serine
   • No substrate identified
   • No mechanistic pathway placement
4. 2020 Medium

   Identifying ESD as a nonclassical Ser/Thr deacetylase acting on JAB1 placed it in a defined signaling axis controlling cholesterol efflux, moving ESD from an enzyme of unknown physiological substrate to a regulator of lipid metabolism.

   Evidence Co-immunoprecipitation, cell-based deacetylase assay for JAB1 Thr89, lysosomal fractionation, apoE-/- high-fat-diet mouse model, foam cell assay, and pharmacological activation with FPD5

   PMID:33615471

   Open questions at the time

   • Single lab without independent replication
   • Mechanism of ESD lysosomal aggregation and JAB1 recruitment not structurally defined
   • Direct enzymatic measurement of deacetylation kinetics on a purified substrate not established

• Whether the cataloged ESD coding variants alter its deacetylase/esterase activity or the JAB1–ABCA1 cholesterol-efflux axis remains unresolved, and the full substrate repertoire of ESD beyond JAB1 is unknown.
• No genotype-to-activity mapping for ESD variants
• No substrate beyond JAB1 Thr89 characterized
• No structural model of substrate engagement